Irinotecan Drug-Eluting Beads in the Treatment of Chemo-Naive Unresectable Colorectal Liver Metastasis with Concomitant Systemic Fluorouracil and Oxaliplatin: Results of Pharmacokinetics and Phase I Trial

Pharmacokinetics of irinotecan: Comparison of intravenous and intra-arterial administration in patients with liver metastases

(2017) A. Mambrini et al.   JOURNAL OF CLINICAL ONCOLOGY

Hepatic Intra-Arterial Injection of Drug-Eluting Bead, Irinotecan (DEBIRI) in Unresectable Colorectal Liver Metastases Refractory to Systemic Chemotherapy: Results of Multi-Institutional Study

(2010) Robert C. G. Martin et al.   ANNALS OF SURGICAL ONCOLOGY

Toxicity of Irinotecan-Eluting Beads in the Treatment of Hepatic Malignancies: Results of a Multi-Institutional Registry

(2010) R. C. G. Martin et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study

(2010) Matthew Bower et al.   HPB

Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: is it safe?

(2010) Russell E. Brown et al.   HPB

Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report

(2009) Robert CG Martin et al.   World Journal of Surgical Oncology

Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry

(2009) Robert C. G. Martin et al.   Journal of Oncology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER